Minipress (Pfizer Laboratories Div Pfizer Inc)
Welcome to the PulseAid listing for the Minipress drug offered from Pfizer Laboratories Div Pfizer Inc. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Pfizer Laboratories Div Pfizer Inc |
NON-PROPRIETARY NAME: | prazosin hydrochloride |
SUBSTANCE NAME: | PRAZOSIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1994-05-10 |
END MARKETING DATE: | 0000-00-00 |
Minipress HUMAN PRESCRIPTION DRUG Details:
Item Description | Minipress from Pfizer Laboratories Div Pfizer Inc |
LABELER NAME: | Pfizer Laboratories Div Pfizer Inc |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/1) |
START MARKETING DATE: | 1994-05-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0069-4310_e011bf03-a807-4b05-ac08-0db8b7194099 |
PRODUCT NDC: | 0069-4310 |
APPLICATION NUMBER: | NDA017442 |
Other PRAZOSIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: